000 01456 a2200409 4500
005 20250516175806.0
264 0 _c20140818
008 201408s 0 0 eng d
022 _a1477-2566
024 7 _a10.1016/j.jcyt.2013.08.008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTanimoto, Kazushi
245 0 0 _aGenetically engineered fixed K562 cells: potent "off-the-shelf" antigen-presenting cells for generating virus-specific T cells.
_h[electronic resource]
260 _bCytotherapy
_cJan 2014
300 _a135-46 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntigen-Presenting Cells
_ximmunology
650 0 4 _aCD8-Positive T-Lymphocytes
_ximmunology
650 0 4 _aCytomegalovirus Infections
_ximmunology
650 0 4 _aGenetic Engineering
650 0 4 _aHLA Antigens
_ximmunology
650 0 4 _aHumans
650 0 4 _aK562 Cells
650 0 4 _aLeukocytes, Mononuclear
_ximmunology
650 0 4 _aLymphocyte Activation
_ximmunology
650 0 4 _aT-Lymphocytes, Cytotoxic
_ximmunology
700 1 _aMuranski, Pawel
700 1 _aMiner, Samantha
700 1 _aFujiwara, Hiroshi
700 1 _aKajigaya, Sachiko
700 1 _aKeyvanfar, Keyvan
700 1 _aHensel, Nancy
700 1 _aBarrett, A John
700 1 _aMelenhorst, J Joseph
773 0 _tCytotherapy
_gvol. 16
_gno. 1
_gp. 135-46
856 4 0 _uhttps://doi.org/10.1016/j.jcyt.2013.08.008
_zAvailable from publisher's website
999 _c23217509
_d23217509